Syndax Pharmaceuticals, Inc.
(SNDX - NASDAQ)
21,00 USD
📋 Profilo Aziendale

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer.

|